Judith Kelleher-Andersson
Gründer bei NeuroNascent, Inc.
Aktive Positionen von Judith Kelleher-Andersson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
NeuroNascent, Inc.
 NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Direktor/Vorstandsmitglied | 01.01.2004 | - |
| Vorstandsvorsitzender | 01.01.2004 | - | |
| Gründer | 01.01.2004 | - | |
| Präsident | 01.01.2004 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | 01.01.2014 |
Karriereverlauf von Judith Kelleher-Andersson
Ehemalige bekannte Positionen von Judith Kelleher-Andersson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Centaur Pharmaceuticals, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| RESPIRERX PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| PALISADE BIO, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Judith Kelleher-Andersson
| University of Missouri | Doctorate Degree |
| University of California, Berkeley | Graduate Degree |
| St. Anselm College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
Operativ
| Chief Tech/Sci/R&D Officer | 4 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Health Technology | 5 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| RESPIRERX PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
NeuroNascent, Inc.
NeuroNascent, Inc. Pharmaceuticals: MajorHealth Technology NeuroNascent, Inc. is an IND-enabling stage biopharmaceutical company that develops orally available, novel therapeutics aimed at halting or reversing chronic neurological disorders. It offers disease-modifying therapeutics for some of the most difficult to treat brain disorders that include Alzheimer's disease, Parkinson's disease, and Down syndrome. The Company is founded by Judith Kelleher-Andersson in May 2004 and is headquartered in Clarksville, MD. | Health Technology |
Seneca Biopharma, Inc.
 Seneca Biopharma, Inc. BiotechnologyHealth Technology Seneca Biopharma, Inc. operates as a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel & proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD. | Health Technology |
| Centaur Pharmaceuticals, Inc. | Health Technology |
